Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Biomaterials
|
June 1, 2016
Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4
Linda Foit, C Shad Thaxton
Methods in Molecular Biology (Clifton, N.J.)
|
March 23, 2011
Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study
Aaron C Eifler, C Shad Thaxton
Nature Biotechnology
|
June 9, 2005
Plasmon coupling measures up
C Shad Thaxton, Chad A Mirkin
Expert Review of Anticancer Therapy
|
June 1, 2019
An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy
Stephen E Henrich, C Shad Thaxton
Journal of Materials Chemistry. B
|
April 13, 2016
High-Density Lipoproteins for Therapeutic Delivery Systems
R Kannan Mutharasan, Linda Foit, C Shad Thaxton
Oncoscience
|
July 24, 2018
HDL and the golden key to cancer immunity?
Michael P Plebanek, Debayan Bhaumik, C Shad Thaxton
Expert Review of Molecular Diagnostics
|
November 5, 2004
Nanostructures in biodefense and molecular diagnostics
Chad A Mirkin, C Shad Thaxton, Nathaniel L Rosi
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 11, 2005
Gold nanoparticle probes for the detection of nucleic acid targets
C Shad Thaxton, Dimitra G Georganopoulou, Chad A Mirkin
Science (New York, N.Y.)
|
September 27, 2003
Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins
Jwa-Min Nam, C Shad Thaxton, Chad A Mirkin
Angewandte Chemie (International Ed. in English)
|
October 16, 2004
Control of nanoparticle assembly by using DNA-modified diatom templates
Nathaniel L Rosi, C Shad Thaxton, Chad A Mirkin
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Biomaterials
|
June 1, 2016
Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4
Linda Foit, C Shad Thaxton
Methods in Molecular Biology (Clifton, N.J.)
|
March 23, 2011
Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study
Aaron C Eifler, C Shad Thaxton
Nature Biotechnology
|
June 9, 2005
Plasmon coupling measures up
C Shad Thaxton, Chad A Mirkin
Expert Review of Anticancer Therapy
|
June 1, 2019
An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy
Stephen E Henrich, C Shad Thaxton
Journal of Materials Chemistry. B
|
April 13, 2016
High-Density Lipoproteins for Therapeutic Delivery Systems
R Kannan Mutharasan, Linda Foit, C Shad Thaxton
Oncoscience
|
July 24, 2018
HDL and the golden key to cancer immunity?
Michael P Plebanek, Debayan Bhaumik, C Shad Thaxton
Expert Review of Molecular Diagnostics
|
November 5, 2004
Nanostructures in biodefense and molecular diagnostics
Chad A Mirkin, C Shad Thaxton, Nathaniel L Rosi
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 11, 2005
Gold nanoparticle probes for the detection of nucleic acid targets
C Shad Thaxton, Dimitra G Georganopoulou, Chad A Mirkin
Science (New York, N.Y.)
|
September 27, 2003
Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins
Jwa-Min Nam, C Shad Thaxton, Chad A Mirkin
Angewandte Chemie (International Ed. in English)
|
October 16, 2004
Control of nanoparticle assembly by using DNA-modified diatom templates
Nathaniel L Rosi, C Shad Thaxton, Chad A Mirkin
Page
of 8